Stockscreener 앱 받기
1.36
6.85%
-0.10
시간 외 거래:
1.39
0.03
+2.21%
전일 마감가:
$1.46
열려 있는:
$1.42
하루 거래량:
3.91M
Relative Volume:
1.72
시가총액:
$1.08B
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-7.1579
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
-9.33%
1개월 성능:
-12.26%
6개월 성능:
-1.45%
1년 성능:
-9.93%
1일 변동 폭
$1.35
$1.44
1주일 범위
$1.35
$1.51
52주 변동 폭
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
OPK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.36 | 1.12B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Will OPKO Health Inc. (XCY) stock beat growth indexes2025 Performance Recap & High Accuracy Trade Alerts - newser.com
Can OPKO Health Inc. (XCY) stock double in coming yearsWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Can OPKO Health Inc. (XCY) stock hold up in economic slowdownProfit Target & Step-by-Step Trade Execution Guides - newser.com
Is OPKO Health Inc. (XCY) stock a defensive play amid uncertaintyPortfolio Profit Report & High Yield Equity Trading Tips - newser.com
Is OPKO Health Inc. building a consolidation basePortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Can technical indicators confirm OPKO Health Inc.’s reversalQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Top chart patterns to watch in OPKO Health Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Can a trend reversal in OPKO Health Inc. lead to recoveryBull Run & Verified Technical Signals - newser.com
Will OPKO Health Inc. stock benefit from green energy trendsQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Regression analysis insights on OPKO Health Inc. performanceSwing Trade & Reliable Trade Execution Plans - newser.com
Opko Health director Frost buys $213k in shares By Investing.com - Investing.com Canada
OPKO Health, Inc. (OPK) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Opko Health director Frost buys $213k in shares - Investing.com
OPKO Health Reports Q3 2025 Earnings and Strategic Moves - MSN
Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance
OPKO Health Shares Fall After Jefferies Downgrade - MarketScreener
Jefferies Downgrades OPK: Price Target Lowered by 20% | OPK Stoc - GuruFocus
Barrington Research Reiterates "Outperform" Rating for OPKO Health (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q3 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
Will OPKO Health Inc. (XCY) stock enhance shareholder valueMarket Performance Summary & Precise Swing Trade Alerts - newser.com
When is the best time to exit OPKO Health Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
How to read the order book for OPKO Health Inc.Quarterly Profit Review & Smart Allocation Stock Tips - newser.com
Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - MSN
OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance
Is OPKO Health Inc. stock supported by strong fundamentalsJuly 2025 Institutional & Weekly Breakout Watchlists - newser.com
OPKO Health Inc (OPK) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Performance By GuruFocus - Investing.com Canada
Jefferies downgrades Opko Health stock to Hold on flat Ngenla sales - Investing.com Nigeria
OPKO Health (NASDAQ:OPK) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance
How OPKO Health Inc. (XCY) stock performs during market turbulenceJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
How to use Fibonacci retracement on OPKO Health Inc.Trade Risk Assessment & Capital Efficiency Focused Ideas - newser.com
Barrington Research Maintains OPKO Health (OPK) Outperform Recommendation - Nasdaq
OPKO Health: Q3 Earnings Snapshot - theheraldreview.com
Published on: 2025-10-29 21:45:43 - newser.com
OPKO Health Q3 Earnings Preview - MSN
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics - sharewise.com
OPKO Health Swaps Lab Assets And Trims Costs For Steadier Profits - Finimize
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.00%
자본화:
|
볼륨(24시간):